Association of Methylenetetrahydrofolate Reductase (MTHFR 677C>T and 1298A>C) Polymorphisms and Haplotypes with Silent Brain Infarction and Homocysteine Levels in a Korean Population

키워드

참고문헌 (42)

1. Kobayashi S, "Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors", Stroke, 22, pp.1379~1383 (1991)
2. Kohara K, "MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA Study", Stroke, 34, pp.1130~1135 (2003)
3. Bernick C, "Silent MRI infarcts and the risk of future stroke: the cardiovascualr health study", Neurology, 57, pp.1222~1229 (2001)
4. Kobayashi S, "Subcortical silent brain infarction as a risk factor for clinical stroke", Stroke, 28, pp.1932~1939 (1997)
5. Uehara T, "Risk factors for silent cerebral infarcts in subcortical white matter and basal ganglia", Stroke, 30, pp.378~382 (1999)
6. Szolnoki Z, "Chemical events behind leukoaraiosis: medicinal chemistry offers new insight into a specific microcirculation disturbance in the brain (a chemical approach to a frequent cerebral phenotype)", Curr Med Chem, 14, pp.1027~1036 (2007)
7. Szolnoki Z, "Pathomechanism of leukoaraiosis: a molecular bridge between the genetic, biochemical, and clinical processes (a mitochondrial hypothesis)", Neuromolecular Med, 9, pp.21~33 (2007)
8. Notsu Y, "Evaluation of genetic risk factors for silent brain infarction", Stroke, 30, pp.1881~1886 (1999)
9. Boushey CJ, "A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes", JAMA, 274, pp.1049~1057 (1995)
10. Kim NK, "Hyperhomocysteinemia as an independent risk factor for silent brain infarction", Neurology, 61, pp.1595~1599 (2003)
11. Matsui T, "Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people", Stroke, 32, pp.1116~1119 (2001)
12. Vermeer SE, "Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study", Ann Neurol, 51, pp.285~289 (2002)
13. Clarke R, "Hyperhomocysteinemia: an independent risk factor for vascular disease", N Engl J Med, 324, pp.1149~1155 (1991)
14. Friedman G, "A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations", J Nutr, 129, pp.1656~1661 (1999)
15. Frosst P, "A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase", Nat Genet, 10, pp.111~113 (1995)
16. Lievers KJ, "A second common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its relationship to MTHFR enzyme activity, homocysteine, and cardiovascular disease risk", J Mol Med, 79, pp.522~528 (2001)
17. van der Put NM, "A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?", Am J Hum Genet, 62, pp.1044~1051 (1998)
18. Choi BO, "Homozygous C677T mutation in the MTHFR gene as an independent risk factor for multiple small-artery occlusions", Thromb Res, 111, pp.39~44 (2003)
19. Girelli D, "The interaction between MTHFR 677C-->T genotype and folate status is a determinant of coronary atherosclerosis risk", J Nutr, 133, pp.1281~1285 (2003)
20. Heijmans BT, "A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer", Cancer Res, 63, pp.1249~1253 (2003)
21. Kim NK, "Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion", Thromb Res, 117, pp.653~658 (2006)
22. Ko KH, "Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population", Anticancer Res, 26, pp.4229~4233 (2006)
23. Nelen WL, "Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis", Fertil Steril, 74, pp.1196~1199 (2000)
24. Ou CY, "5,10 Methylenetetrahydrofolate reductase genetic polymorphism as a risk factor for neural tube defects", Am J Med Genet, 63, pp.610~614 (1996)
25. Matsuo K, "Association between polymorphisms of folate-and methionine-metabolizing enzymes-and susceptibility to malignant lymphoma", Blood, 97, pp.3205~3209 (2001)
26. Sazci A, "Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C", Brain Res Bull, 71, pp.45~50 (2006)
27. Shen H, "Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study", Int J Cancer, 95, pp.332~336 (2001)
28. Song C, "Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population", Cancer Res, 61, pp.3272~3275 (2001)
29. Stegmann K, "Linkage disequilibrium of MTHFR genotypes 677C", T-1298A, Am J Med Genet, pp.1999, 87[DOI]
30. van der Put NM, "A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?", Am J Hum Genet, 62, pp.1044~1051 (1998)
31. Weisberg I, "A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity", Mol Genet Metab, 64, pp.169~172 (1998)
32. Isotalo PA, "Neonatal and fetal methyle-netetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations", Am J Hum Genet, 67, pp.986~990 (2000)
33. Zetterberg H, "Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos", Eur J Hum Genet, 10, pp.113~118 (2002)
34. Bae J, "Prevalent genotypes of methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in spontaneously aborted embryos", Fertil Steril, 87, pp.351~355 (2007)
35. Krajinovic M, "Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia", Blood, 103, pp.252~257 (2004)
36. Chango A, "5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort", Br J Nutr, 84, pp.891~896 (2000)
37. 김남근, "건강한 한국인에서 5,10-Methylenetetrahydrofolate Reductase (MTHFR C677T 와 A1298C) 유전자 돌연변이 연구", 한국유전학회지, 24(2), pp.227~234 (2002), 한국유전학회
38. Kluijtmans LA, "Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults", Blood, 101, pp.2483~2488 (2003)
39. Kim HN, "Association between folate-metabolizing pathway polymorphism and non-Hodgkin lymphoma", Br J Haematol, 140, pp.287~294 (2008)
40. Wiemels JL, "Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia", Proc Natl Acad Sci U S A, 98, pp.4004~4009 (2001)
41. Gebhardt GS, "Combined heterozygosity for methylenetetrahydrofolate reductase (MTHFR) mutations C677T and A1298C is associated with abruptio placentae but not with intrauterine growth restriction", Eur J Obstet Gynecol Reprod Biol, 97, pp.174~177 (2001)
42. Kim JK, "Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population", Anticancer Res, 25, pp.2249~2252 (2005)

관련 논문AI추천